The purpose of this study is to compare the effects of moderate versus vigorous intensity exercise training on glycemic control in older adults. Glycemic control will be assessed using an oral glucose tolerance test and continuous glucose monitors. In addition, the investigaotrs will investigate whether engaging in an exercise training program elicits changes in sedentary behavior, non-exercise physical activity, sleep, and total daily energy expenditure.
Approximately 25% of older adults have type 2 diabetes mellitus, and almost 50% of older adults have prediabetes. Identifying strategies to prevent the progression of diabetes in this older adult population is imperative. One strategy that has shown promise is lifestyle modification. As adults age they also increase sedentary behavior, decrease physical activity, and have increased occurrence of sleep problems. The combination of these lifestyle factors are likely responsible for the decreases in glycemic control with aging. The American Diabetes Association recommends that prediabetic adults, including older adults, increase structured aerobic exercise and incidental (non-exercise) physical activity while decreasing sedentary behavior. It is emphasized that structured exercise is the most important of these recommendations. However, initiating an exercise routine, may unintentionally affect time spent sitting, non-exercise physical activity, and other lifestyle behaviors like sleep. These changes may attenuate or enhance the effects of exercise on glycemic control. This study will compare the effects of moderate and high intensity exercise on glycemic control, and determine whether changes in non-exercise physical activity, sitting time, and sleep are associated with the observed changes. Because of the increasing prevalence of diabetes with age, identifying the optimal exercise prescription to preserve glycemic control in older adults has important clinical implications.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
20
For the first 4 weeks, participant will be asked to complete 3 days of exercise/week at 50-65% heart rate maximum. Sessions will last between 30-40 minutes excluding the warm-up and cool down (5-10 minutes). After 4 weeks, the MOD group will be expected to match the exercise prescription. The exercise prescription for the MOD group for weeks 5-12 will be 4 days/week, 45 min/session completed at 60-65% heart rate maximum.
The exercise lead in period will be the same as the moderate intensity exercise training program. After 6 weeks, the VIG group will be expected to match the exercise prescription. The exercise prescription for the VIG for weeks 7-12 will be 4 days/week, 45 min/session completed at 80-85% heart rate maximum.
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Change in Glucose Area Under the Curve (AUC)
Glucose will be assessed at 0, 10, 20, 30, 60, 90, 120, 180 minutes. These measurements will be used to calculate glucose AUC.
Time frame: Baseline (0 weeks), Post Intervention (12 weeks)
Insulin Sensitivity Index (μmol·kg^-1·min^-1·pM^-1)
Glucose, insulin, and c-peptide will be assessed at 0, 10, 20, 30, 60, 90, 120, 180 minutes . Height will be measured using a wall mounted stadiometer (cm). Weight will be assessed using a digital scale (kg). Collectively these measurements will be used to calculate BMI (kg/m\^2). All of these measurement will be used to assess Insulin sensitivity index as determined by the regression model validated by Stumvoll.
Time frame: Baseline (0 weeks), Post Intervention (12 weeks)
Change in Sedentary Time
Measured using a wearable device (min/day)
Time frame: Baseline (0 weeks), Post Intervention (12 weeks)
Change in Non-Exercise Physical Activity
Measured using a wearable device (min/day)
Time frame: Baseline (0 weeks), Post Intervention (12 weeks)
Change in Total Daily Energy Expenditure
Measured via doubly labeled water (kcals/day)
Time frame: Baseline (0 weeks), Post Intervention (12 weeks)
Change in Sleep Duration - 1
Measured using a wearable device
Time frame: Baseline (0 weeks), Post Intervention (12 weeks)
Change in Sleep Duration - 2
Measured using a questionnaire
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline (0 weeks), Post Intervention (12 weeks)
Change in 24-hour Glycemic Control (glucose AUC)
Measured using a continuous glucose monitor (glucose AUC)
Time frame: Baseline (0 weeks), Post Intervention (12 weeks)